Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 14,070
+110 (0.79%)
At close: Mar 6, 2026
Cell Biotech Revenue
Cell Biotech had revenue of 15.36B KRW in the quarter ending September 30, 2025, with 26.25% growth. This brings the company's revenue in the last twelve months to 50.65B, down -3.71% year-over-year. In the year 2024, Cell Biotech had annual revenue of 49.91B, down -7.20%.
Revenue (ttm)
50.65B
Revenue Growth
-3.71%
P/S Ratio
1.84
Revenue / Employee
501.47M
Employees
101
Market Cap
93.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.91B | -3.87B | -7.20% |
| Dec 31, 2023 | 53.79B | 3.26B | 6.46% |
| Dec 31, 2022 | 50.53B | 3.65B | 7.79% |
| Dec 31, 2021 | 46.87B | 1.29B | 2.83% |
| Dec 31, 2020 | 45.58B | -377.42M | -0.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 132.76B |
| Progen | 450.00M |
| KoBioLabs | 71.83B |
| TegoScience | 6.15B |
| Quratis | 2.28B |
| Parataxis Korea | 10.10M |
| Choong Ang Vaccine Laboratory | 39.19B |
| IMGT Co.,Ltd. | 102.33M |